DOCSLIB.ORG

Genetic Testing in Pediatrics - a Narrative Essay of Challenges and Possibilities in Romania Carmen Duicu*

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Genetic Testing in Pediatrics - a Narrative Essay of Challenges and Possibilities in Romania Carmen Duicu* Revista Română de Medicină de Laborator Vol. 27, Nr. 4, Octombrie, 2019 355 Editorial DOI:10.2478/rrlm-2019-0041 Genetic testing in pediatrics - a narrative essay of challenges and possibilities in Romania Carmen Duicu* 1st Pediatric Department, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, Romania Received: 30th September 2019; Accepted: 10th October 2019; Published: 20th October 2019 In spite of extensive medical examinations, they are important for appropriate management, many pediatric patients remain without a clear prognosis and genetic counseling of the families. diagnosis. The genetic testing is necessary in For example, in genetic forms the relapse of ne- the evaluation of some of these challenging cas- phrotic syndrome (NS) kidney transplantation is es after a thorough evaluation in the attempt to unusual. In a previous report, the importance of identify the cause, and for appropriate treatment this investigation in late-onset SRNS was proved or genetic counseling when necessary. Newer again (2). genetic techniques are more available in pedi- Genetic testing enables identification of the ge- atric practice due to up-to-date progression and netic causes of intellectual disabilities in an in- advancement in genetic research and their rapid creased number of children, especially in those use in clinical practice. cases which associate congenital anomalies and Genetic investigation enables pediatricians to facial dysmorphia. In recent years, multiple avoid invasive testing [like muscle biopsies in studies have clearly demonstrated that molecu- Duchene muscular dystrophy (DMD) or kidney lar genetic tests are recommended instead of cy- biopsy in Steroid-resistant nephrotic syndrome togenetic analysis, with the exception of those (SRNS)]. Genetic testing may help clinicians cases with a clinically recognizable aneuploidy to avoid harmful therapies (in SRNS cases), to syndrome (Down syndrome, Patau syndrome, decide the intensity and duration of immuno- Edwards syndrome, etc.) or in those patients suppression in SRNS and pre-transplantation with a family history of balanced translocations. therapy, to establish which medications may be Patients with intellectual disability (ID) and mul- contraindicated or are most effective, and also tiple congenital anomalies (MCAs) may associ- to provide a well-informed genetic counseling ate copy number variations (CNVs) represented to the family (1). Even if some of the genetic by small losses (deletions, del) and gains (dupli- techniques are expensive and time-consuming, cations, dup) of genetic material (DNA sample). *Corresponding author: Carmen Duicu, 1st Pediatric Department, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, Romania. E-mail: [email protected]; carmen.duicu@ rrml.ro 356 Revista Română de Medicină de Laborator Vol. 27, Nr. 4, Octombrie, 2019 The CNV may be uncovered by chromosomal (15%) in GBA gene compared to Cau casian non- microarray analysis (CMA), such as compara- Jews patients (7). The same researchers proved tive genomic hybridization arrays (aCGH) and that plasma chitotriosidase is a useful biomarker single nucleotide polymorphism array (aSNP), for treatment response evaluation. considered until recently the first-line genetic in- The response to antiepileptic drugs (AEDs) var- vestigation in ID cases. Certainly, CMA testing ies between patients with epilepsy (8). Recently, has improved the diagnosis in patients with ID. it has been shown that testing for gene variations In recent years, the multiplex ligation-dependent that might predict adverse reactions (ADRs) and probe amplification (MLPA) method has been drug response will improve the effectiveness and reported to be a useful, fast and cost-effective safety of epilepsy therapies, leading to a preci- test for the evaluation of children with ID (3, 4), sion medicine treatment. Two studies that inves- especially in ID associated syndromes. Recently, tigated Romanian children with epilepsy showed a meta-analysis performed by Srivastava et al. that ABCB1 (T129C, C1236T, and G2677T) recommended exome sequencing as a first-tier gene polymorphisms are not associated with test especially in patients with unexplained neu- epilepsy and drug responsiveness (9, 10) but an rodevelopmental disorders (5). association between ABCB1 T129C and AEDs Lysosomal storage diseases (LSD), caused by concentrations was noticed (10). the deficiency of lysosomal enzymes or non-en- Among birth abnormalities, heart defects are the zyme proteins, recognize early or late‐onset most frequent, with varying severity degrees. forms. LSDs are known to have a wide spectrum Genetics and environmental factors are sup- of phenotypes and multiorgan involvement. For posed to be involved in congenital heart defect these cases, biochemical analyses are important etiology. When congenital heart defects (CHD) for diagnosis, but genetic analysis is necessary occur together with extra-cardiac anomalies for a precise diagnosis, successful treatment and like intellectual disability, developmental de- also for genetic counseling. Many techniques for lay, dysmorphic face, palatal defects, kidney or genetic analysis were used in the LSDs diagno- ocular abnormalities, etc. they may suggest the sis: restriction fragment length polymorphism presence of a genetic syndrome. Common ge- (RFLP), amplification-refractory mutation sys- netic syndromes associated with different con- tem (ARMS), real-time polymerase chain reac- genital heart disease are Down syndrome and tion, high resolution melting (HRM), multiplex microdeletion syndromes like DiGeorge syn- ligation-dependent probe amplification (MLPA), drome (22q11.2 deletion syndrome), Williams Sanger sequencing and also the newer method syndrome (7q11.23 microdeletion). In the case next‐generation sequencing (NGS) (6). For mo- of microdeletion syndrome fluorescence in situ ment enzyme replacement therapy (ERT) rep- hybridization (FISH) analysis or molecular in- resents the current therapeutic option until gene vestigation (MLPA) are necessary. In the case therapy becomes available. The most frequent of disorders produced by gene mutation such as LSD is Gaucher Disease (GD). There is a well- Noonan syndrome DNA sequencing analyses known genotype-phe notype correlation in Gau- are necessary to detect mutations in the PTPN11, cher disease. A recent study that involved 69 GD RAF1, SOS1, KRAS, NRAS, BRAF, SHOC2 cases emphasized the ge netic particularities of or MEK1 genes, found in almost 75% of cases. this disease in Romanian patients and revealed Noonan syndrome (NS), and related syndromes a higher frequency of N370S/L444P compound [Costello syndrome (CS), cardiofaciocutaneous heterozygotes (35%) and N370S homozygotes syndrome (CFCS), and LEOPARD syndrome] Revista Română de Medicină de Laborator Vol. 27, Nr. 4, Octombrie, 2019 357 are caused by mutations in RAS signaling path- translocations) has become essential for diagno- way genes. The precise diagnosis in these cases is sis, risk-stratification, management of these dis- tremendous as children with „RASopathy” have eases and monitoring of treatment response (15). an increased risk of childhood cancer (leukemia Cryptic cytogenetic alterations may be revealed and solid tumors), so they need close follow-up by CMA and by MLPA methods (16). Fusion (11). In cases with multiple congenital anoma- genes, the result of chromosomal translocation, lies such as Emanuel syndrome, the karyotyping are important for risk stratification and may be (conventional and/ or molecular) represents the used as prognostic markers in children with ALL first-line of genetic evaluation. If a small super- (15). Genomic studies in ALL are of clinical im- numerary marker chromosome (sSMC) is de- portance and are expected to improve diagnosis, tected by conventional karyotyping, the MLPA monitoring of minimal residual disease (MRD), analysis may represents the choice for a fast and early detection of relapse, and for implementa- cost-effective method compared to genome array tion of targeted therapy (17). Molecular testing and FISH to establish its origin (3). is necessary for children with hematological Pulmonary arterial hypertension (PAH) is a rare malignancy. A few studies considered that nuc- and sometimes lethal complication in CHD. leophosmin 1 (NPM1) and transcription factor Compared with adults, in children the response CCAAT/enhancer-binding protein α (CEBPA) to treatment is inferiors and the prognosis is mutations defined a particular children AML worse. Genetic studies proved the role of genetic subgroup with good prognosis and are rare in factors in the pathogenesis of PAH [bone mor- MDS. The prognostic significance of FLT3 (fms phogenetic protein receptor 2 (BMPR2) gene; related tyrosine kinase 3) gene mutation is con- activin A, receptor type II-like 1 (ACVRL1)]. troversial in childhood AML (17). Taking into Mutations in other genes including T-box4 account that NPM1, FLT3 somatic mutation are (TBX4), BMPR1B and neurogenic locus notch not well-characterized in leukemic children, fur- homolog 3 (NOTCH3) are involved in pediat- ther studies are needed. ric PAH (12). A significantly higher frequen- Obesity is a worldwide epidemic problem, with cy of TBX4 mutations in pediatric-onset PAH patients was observed, with a 20-year earlier an alarming prevalence increasing especially in age-of-onset compared with BMPR2 mutation our country. It is a multifactorial disease, every carriers (13).
Load more

Recommended publications
  • The Advantage of Genome-Wide Microarrays Over Targeted Approaches
    PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/70828 Please be advised that this information was generated on 2021-09-24 and may be subject to change. COPY NUMBER VARIATION AND MENTAL RETARDATION opmaak koolen.indd 1 10-09-2008 10:11:31 Copy number variation and mental retardation The studies presented in this thesis were performed at the Department of Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands. The research was supported by a grant from the Netherlands Organization for Health Research and Development (ZonMw). Publication of this thesis was financially supported by the Department of Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands. ISBN/EAN 978-90-6464-290-6 © 2008 D.A. Koolen All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, by print or otherwise, without permission in writing from the author. Cover photo: Printed by: Ponsen & Looijen B.V., Wageningen opmaak koolen.indd 2 10-09-2008 10:11:31 Copy number variation and mental retardation Een wetenschappelijke proeve op het gebied van de Medische Wetenschappen Proefschrift ter verkrijging van de graad doctor aan de Radboud Universiteit Nijmegen op gezag van de rector magnificus prof. mr. S.C.J.J. Kortmann, volgens besluit van het College van Decanen in het openbaar te verdedigen op donderdag 6 november 2008 om 15.30 uur precies door David Aljosja Koolen geboren op 22 juni 1976 te ‘s-Gravenhage opmaak koolen.indd 3 10-09-2008 10:11:32 Promotor: Prof.
    [Show full text]
  • Whole Chromosome Gain Does Not in Itself Confer Cancer-Like Chromosomal Instability
    Whole chromosome gain does not in itself confer cancer-like chromosomal instability Anders Valinda,1, Yuesheng Jina, Bo Baldetorpb, and David Gisselssona aDepartment of Clinical Genetics, Lund University, University and Regional Laboratories, Biomedical Center B13, Lund SE22184, Sweden; and bDepartment of Oncology, Lund University, Skåne University Hospital, Lund SE22185, Sweden Edited* by George Klein, Karolinska Institutet, Stockholm, Sweden, and approved November 4, 2013 (received for review June 12, 2013) Constitutional aneuploidy is typically caused by a single-event and chromosomal instability in humans is using constitutional meiotic or early mitotic error. In contrast, somatic aneuploidy, aneuploidy syndromes as a model. Cells from patients with these found mainly in neoplastic tissue, is attributed to continuous syndromes provide a good experimental system for studying the chromosomal instability. More debated as a cause of aneuploidy effects of aneuploidy on overall genome stability on representative is aneuploidy itself; that is, whether aneuploidy per se causes human material. Such cells typically only have a single or a limited chromosomal instability, for example, in patients with inborn set of stem-line chromosome aberrations compared with tumor aneuploidy. We have addressed this issue by quantifying the level cell lines, which typically harbor a multitude of genetic lesions, as of somatic mosaicism, a proxy marker of chromosomal instability, well as a cancer phenotype. The few earlier studies performed on in patients with
    [Show full text]
  • 95 Birth Defects Exec Summ
    Executive Summary In 1995, 865 cases of birth defects were detected among live born infants and fetuses of 20 or more weeks gestation delivered to mothers residing in Texas Public Health Regions 6 and 11 (Houston/Galveston region and Lower Rio Grande Valley). In this first full year of the Registry, surveillance was limited to approximately 23 major categories of birth defects, comprising 30 to 40 percent of all known structural malformations. Down syndrome, oral clefts, and spina bifida were the most common birth defects, although some major structural malformations were not yet monitored in 1995. Age Patterns: Both trisomy 21 (Down syndrome) and trisomy 18 (Edwards syndrome) demonstrated an age-specific rate pattern that was J-shaped, with the highest birth prevalence (“rates”) observed among mothers 35 years of age and older. Gastroschisis, a malformation of the abdominal wall, exhibited highest rates among the youngest mothers and decreased with each older age group. Racial/Ethnic Patterns: Anencephaly and spina bifida were lowest among African Americans; however, rates were similar in whites and Hispanics. Among the heart defects, relatively high rates of tetralogy of Fallot were observed among African Americans, although they exhibited relatively low rates of hypoplastic left heart. Cleft palate alone was more likely to occur among whites and Hispanics. Rates of trisomy 18 (Edwards syndrome) were highest among African Americans and whites. Gender Patterns: With regard to sex, higher rates were documented among females for anencephaly, and to a lesser extent, spina bifida. Females experienced two-fold higher rates of trisomy 18 (Edwards syndrome). Males had higher rates of cleft lip with or without cleft palate.
    [Show full text]
  • Cytogenetics, Chromosomal Genetics
    Cytogenetics Chromosomal Genetics Sophie Dahoun Service de Génétique Médicale, HUG Geneva, Switzerland [email protected] Training Course in Sexual and Reproductive Health Research Geneva 2010 Cytogenetics is the branch of genetics that correlates the structure, number, and behaviour of chromosomes with heredity and diseases Conventional cytogenetics Molecular cytogenetics Molecular Biology I. Karyotype Definition Chromosomal Banding Resolution limits Nomenclature The metaphasic chromosome telomeres p arm q arm G-banded Human Karyotype Tjio & Levan 1956 Karyotype: The characterization of the chromosomal complement of an individual's cell, including number, form, and size of the chromosomes. A photomicrograph of chromosomes arranged according to a standard classification. A chromosome banding pattern is comprised of alternating light and dark stripes, or bands, that appear along its length after being stained with a dye. A unique banding pattern is used to identify each chromosome Chromosome banding techniques and staining Giemsa has become the most commonly used stain in cytogenetic analysis. Most G-banding techniques require pretreating the chromosomes with a proteolytic enzyme such as trypsin. G- banding preferentially stains the regions of DNA that are rich in adenine and thymine. R-banding involves pretreating cells with a hot salt solution that denatures DNA that is rich in adenine and thymine. The chromosomes are then stained with Giemsa. C-banding stains areas of heterochromatin, which are tightly packed and contain
    [Show full text]
  • Application of Neural Networks for Classification of Patau, Edwards
    Catic et al. BMC Medical Genomics (2018) 11:19 DOI 10.1186/s12920-018-0333-2 RESEARCHARTICLE Open Access Application of Neural Networks for classification of Patau, Edwards, Down, Turner and Klinefelter Syndrome based on first trimester maternal serum screening data, ultrasonographic findings and patient demographics Aida Catic1,2* , Lejla Gurbeta1,4, Amina Kurtovic-Kozaric1,3, Senad Mehmedbasic2 and Almir Badnjevic1,4,5,6 Abstract Background: The usage of Artificial Neural Networks (ANNs) for genome-enabled classifications and establishing genome-phenotype correlations have been investigated more extensively over the past few years. The reason for this is that ANNs are good approximates of complex functions, so classification can be performed without the need for explicitly defined input-output model. This engineering tool can be applied for optimization of existing methods for disease/syndrome classification. Cytogenetic and molecular analyses are the most frequent tests used in prenatal diagnostic for the early detection of Turner, Klinefelter, Patau, Edwards and Down syndrome. These procedures can be lengthy, repetitive; and often employ invasive techniques so a robust automated method for classifying and reporting prenatal diagnostics would greatly help the clinicians with their routine work. Methods: The database consisted of data collected from 2500 pregnant woman that came to the Institute of Gynecology, Infertility and Perinatology “Mehmedbasic” for routine antenatal care between January 2000 and December 2016. During first trimester all women were subject to screening test where values of maternal serum pregnancy- associated plasma protein A (PAPP-A) and free beta human chorionic gonadotropin (β-hCG) were measured. Also, fetal nuchal translucency thickness and the presence or absence of the nasal bone was observed using ultrasound.
    [Show full text]
  • SUPPORTING FAMILIES, CELEBRATING LIVES a WORD from 2 Our Chair
    SUMMER 2019 Soft UK SUPPORTING FAMILIES, CELEBRATING LIVES A WORD FROM 2 Our Chair Welcome to a packed newsletter, full to participate of family stories, information and in some work updates. We hope you enjoy reading being carried and finding out what is going on in out by the University of Leeds, into the world of SOFT UK! the delivery of challenging news There is so much in these pages but after ultrasound scan. They are I would just like to highlight one focusing on identifying the specific article – the blog that Alison Pearson words, phrases and behaviours that (mum to Isabel) has written, with sonographers should use to deliver another mum of a little girl with different types of unexpected or Down’s syndrome, for Public Health challenging news that they identify England on the use of language. during ultrasound. Interestingly, there is no widespread agreement on We know that the words we speak how this should be done. The result can leave a huge impact and create is that sonographers often decide a lasting memory - either good or for themselves what works best, and bad; for those who hear them. Joel their conclusions are not always in Osteen said: "Be careful what you line with parent preferences. say. You can say something hurtful One, small step, but hopefully we in ten seconds, but ten years later, can get your views and experiences the wounds are still there." We hear across and make a difference for that from many families when they families in the future. talk of how they were told of a high Enjoy the rest of the newsletter risk or diagnosis of Trisomy, or when and do keep letting us know your medical professionals talk about the feedback, contributions and ideas for future for their child with Edwards’ or future editions.
    [Show full text]
  • Double Aneuploidy in Down Syndrome
    Chapter 6 Double Aneuploidy in Down Syndrome Fatma Soylemez Additional information is available at the end of the chapter http://dx.doi.org/10.5772/60438 Abstract Aneuploidy is the second most important category of chromosome mutations relat‐ ing to abnormal chromosome number. It generally arises by nondisjunction at ei‐ ther the first or second meiotic division. However, the existence of two chromosomal abnormalities involving both autosomal and sex chromosomes in the same individual is relatively a rare phenomenon. The underlying mechanism in‐ volved in the formation of double aneuploidy is not well understood. Parental ori‐ gin is studied only in a small number of cases and both nondisjunctions occurring in a single parent is an extremely rare event. This chapter reviews the characteristics of double aneuploidies in Down syndrome have been discussed in the light of the published reports. Keywords: Double aneuploidy, Down Syndrome, Klinefelter Syndrome, Chromo‐ some abnormalities 1. Introduction With the discovery in 1956 that the correct chromosome number in humans is 46, the new area of clinical cytogenetic began its rapid growth. Several major chromosomal syndromes with altered numbers of chromosomes were reported, such as Down syndrome (trisomy 21), Turner syndrome (45,X) and Klinefelter syndrome (47,XXY). Since then it has been well established that chromosome abnormalities contribute significantly to genetic disease resulting in reproductive loss, infertility, stillbirths, congenital anomalies, abnormal sexual development, mental retardation and pathogenesis of malignancy [1]. Clinical features of patients with common autosomal or sex chromosome aneuploidy is shown in Table 1. © 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    [Show full text]
  • The Combined Test
    Antenatal Screening Antenatal Screening for Down's syndrome, Edwards syndrome and Patau syndrome The Combined Test Questions and Answers for women considering the test The Wolfson Institute of Preventive Medicine Barts and The London School of Medicine and Dentistry Antenatal Screening This leaflet answers some of the common questions women ask about their screening test – we hope you find it helpful. You are welcome to discuss the test with your midwife or consultant before you decide whether you would like to be screened. If you have any further questions screening staff at the Wolfson Institute are available to talk to you on 020 7882 6293. What is Down's syndrome? What are Edwards and Patau syndrome? Down's syndrome (trisomy 21) is Edwards syndrome (trisomy 18) is defined by the presence of an extra defined by the presence of an extra chromosome number 21 in the cells chromosome number 18 in the cells of the fetus or affected individual. In of the fetus or affected individual an unscreened population about 1 in while Patau syndrome (trisomy 13) every 500 babies is born with Down's is defined by an extra chromosome syndrome. Usually it is not inherited number 13 in the cells of the fetus or and so a baby can be affected affected individual. Both syndromes even if there is no history of Down's affect multiple organs with a high risk syndrome in the family. of fetal death. Down's syndrome is the most At 12 weeks of pregnancy Edwards common cause of severe learning syndrome has a prevalence of about disability and is often associated 1 in 1,500 and Patau syndrome has a with physical problems such as heart prevalence of about 1 in 3,500 in an defects and difficulties with sight and unscreened population.
    [Show full text]
  • Congenital Heart Disease and Chromossomopathies Detected By
    Review Article DOI: 10.1590/0103-0582201432213213 Congenital heart disease and chromossomopathies detected by the karyotype Cardiopatias congênitas e cromossomopatias detectadas por meio do cariótipo Cardiopatías congénitas y anomalías cromosómicas detectadas mediante cariotipo Patrícia Trevisan1, Rafael Fabiano M. Rosa2, Dayane Bohn Koshiyama1, Tatiana Diehl Zen1, Giorgio Adriano Paskulin1, Paulo Ricardo G. Zen1 ABSTRACT Conclusions: Despite all the progress made in recent de- cades in the field of cytogenetic, the karyotype remains an es- Objective: To review the relationship between congenital sential tool in order to evaluate patients with congenital heart heart defects and chromosomal abnormalities detected by disease. The detailed dysmorphological physical examination the karyotype. is of great importance to indicate the need of a karyotype. Data sources: Scientific articles were searched in MED- LINE database, using the descriptors “karyotype” OR Key-words: heart defects, congenital; karyotype; Down “chromosomal” OR “chromosome” AND “heart defects, syndrome; trisomy; chromosome aberrations. congenital”. The research was limited to articles published in English from 1980 on. RESUMO Data synthesis: Congenital heart disease is characterized by an etiologically heterogeneous and not well understood Objetivo: Realizar uma revisão da literatura sobre a group of lesions. Several researchers have evaluated the pres- relação das cardiopatias congênitas com anormalidades ence of chromosomal abnormalities detected by the karyo- cromossômicas detectadas por meio do exame de cariótipo. type in patients with congenital heart disease. However, Fontes de dados: Pesquisaram-se artigos científicos no most of the articles were retrospective studies developed in portal MEDLINE, utilizando-se os descritores “karyotype” Europe and only some of the studied patients had a karyo- OR “chromosomal” OR “chromosome” AND “heart defects, type exam.
    [Show full text]
  • Turner's Syndrome
    SYLLABUS ❑Down’s Syndrome, ❑Inborn errors of metabolism: ❑Turner’s syndrome, phenylketonuria,albinism,galactosemia ❑Kleinfelter’s syndrome, ❑Genetic counseling ❑Edwards syndrome, DOWN SYNDROME • Down syndrome (sometimes called Down’s syndrome) is a condition in which a child is born with an extra copy of their 21st chromosome —hence its other name, trisomy 21. This causes physical and mental developmental delays and disabilities DOWN SYNDROME Causes • In all cases of reproduction, both parents pass their genes on to their children. These genes are carried in chromosomes. • When the baby’s cells develop, each cell is supposed to receive 23 pairs of chromosomes, for 46 chromosomes total. Half of the chromosomes are from the mother, and half are from the father. • In children with Down syndrome, one of the chromosomes doesn’t separate properly. The baby ends up with three copies, or an extra partial copy, of chromosome 21, instead of two. This extra chromosome causes problems as the brain and physical features develop. Types Trisomy 21 • Trisomy 21 means there’s an extra copy of chromosome 21 in every cell. • This is the most common form of Down syndrome. Mosaicism • Mosaicism occurs when a child is born with an extra chromosome in some but not all of their cells. • People with mosaic Down syndrome tend to have fewer symptoms than those with trisomy 21. Translocation • In this type of Down syndrome, children have only an extra part of chromosome 21. There are 46 total chromosomes. However, one of them has an extra piece of chromosome 21 attached. risk factors • . According to the Centers for Disease and Prevention, mothers aged 35 and older are more likely to have a baby with Down syndrome than younger mothers.
    [Show full text]
  • Original Contribution Are Children with Birth Defects at Higher Risk Of
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by ScholarsArchive@OSU Vol. 175, No. 12 American Journal of Epidemiology DOI: 10.1093/aje/kwr470 ª The Author 2012. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Advance Access publication: Public Health. All rights reserved. For permissions, please e-mail: [email protected]. April 24, 2012 Original Contribution Are Children With Birth Defects at Higher Risk of Childhood Cancers? Susan E. Carozza*, Peter H. Langlois, Eric A. Miller, and Mark Canfield * Correspondence to Dr. Susan E. Carozza, School of Biological and Population Health Sciences, College of Public Health and Human Sciences, Oregon State University, Waldo 315, Corvallis, OR 97331 (e-mail: [email protected]). Initially submitted June 30, 2011; accepted for publication November 22, 2011. Downloaded from Birth defects may influence the risk of childhood cancer development through a variety of mechanisms. The rarity of both birth defects and childhood cancers makes it challenging to study these associations, particularly for the very rare instances of each. To address this limitation, the authors conducted a record linkage-based cohort study http://aje.oxfordjournals.org/ among Texas children born between 1996 and 2005. Birth defects in the cohort were identified through the Texas Birth Defects Registry, and children who developed cancer were identified by using record linkage with Texas Cancer Registry data. Over 3 million birth records were included; 115,686 subjects had birth defects, and there were 2,351 cancer cases. Overall, children with a birth defect had a 3-fold increased risk of developing cancer (incidence rate ratio (IRR) ¼ 3.05, 95% confidence interval (CI): 2.65, 3.50), with germ cell tumors (IRR ¼ 5.19, 95% CI: 2.67, 9.41), retinoblastomas (IRR ¼ 2.34, 95% CI: 1.21, 4.16), soft-tissue sarcomas (IRR ¼ 2.12, 95% CI: 1.09, 3.79), and leukemias (IRR ¼ 1.39, 95% CI: 1.09, 1.75) having statistically significant elevated point estimates.
    [Show full text]
  • Soft UK Your Unborn Baby A5 04.10 37045
    SOFT UK Support Organisation for Trisomy 13/18 and related disorders Charity number 1002918 www.soft.org.uk Your Unborn Baby SOFT provides support for families affected by Patau’s syndrome (trisomy 13), Edwards’ syndrome (trisomy 18), partial trisomy, mosaicism, rings, translocation, deletion and related abnormalities and rare conditions including holoprosencephaly. Truth has no special time of its own. Its hour is now. Always. Albert Schweitzer YOUR UNBORN BABY INDEX Section Page About Your Unborn Baby 2 SOFT UK Booklets 4 For Professionals 4 Chromosome Defects, What are They? 5 Trisomy 7 Holoprosencephaly 8 Related Disorders 9 Genetic Information 10 Screening Tests 13 Diagnostic tests 15 Telling Parents 18 Making a Decision 19 When the Pregnancy is Terminated 22 When the Pregnancy Continues 26 Caring for a Baby with a Related Disorder 32 Bereavement 34 How Brothers and Sisters are Affected 39 A New Baby 43 Acknowledgments 45 SOFT UK 45 Information for Parents 45 Other Sources of Support for Parents 47 1 ABOUT YOUR UNBORN BABY Your Unborn Baby was compiled by Rachel Attwell, Jenny Robbins, and Christine Rose, with the help of SOFT medical advisers and families affected by trisomy 13/18 who have shared their own personal experiences. Every family is unique. What may be right for one child or family is not necessarily right for another, and parents can use the shared memories in these booklets as a basis for discussion between themselves and their medical advisers. SOFT does not recommend particular methods of treatment, and new treatment must never be started or existing treatment changed without consultation with your doctor and other medical professionals.
    [Show full text]